BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store? [Yahoo! Finance]
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: Yahoo! Finance
Let's see how things have shaped up for the quarter to be reported. Factors at Play BioNTech's top line currently comprises sales of its mRNA-based COVID-19 vaccine, Comirnaty, developed in partnership with Pfizer PFE. The vaccine is approved in several countries and has been a key contributor to BioNTech's top line. However, following the end of the pandemic, sales of BioNTech/Pfizer's COVID-19 vaccine are likely to have fallen sharply from the year-ago quarter's level. In the fourth quarter, total revenues declined on a reported basis mainly due to the decrease in COVID-19 vaccine sales and the same is likely to have continued in the first quarter. Also, inventory write-downs reported by collaboration partner PFE negatively impacted revenues in the last reported quarter. It remains to be seen whether the same trend continued or reversed in the to-be-reported quarter. The cost of sales declined in the last reported quarter, which is also expected to have prevailed in the
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Evercore ISI. They set an "inline" rating and a $100.00 price target on the stock.MarketBeat
- We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year [Yahoo! Finance Canada]Yahoo! Finance Canada
- We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year [Yahoo! Finance]Yahoo! Finance
- BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HC Wainwright from $107.00 to $113.00. They now have a "buy" rating on the stock.MarketBeat
- BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
BNTX
Earnings
- 5/6/24 - Miss
BNTX
Sec Filings
- 5/6/24 - Form 6-K
- 5/6/24 - Form 6-K
- 4/8/24 - Form 6-K
- BNTX's page on the SEC website